As Rhesus isoimmunization becomes less common, rarer causes of hydrops fetalis assume greater importance. In many cases the aetiology remains unknown. Even when the cause is recognized there is rarely specific treatment and the overall mortality remains high1. Thus, recognition of those cases which have a treatable underlying pathology is important. A case is now reported of hydrops fetalis secondary to congenital toxoplasmosis.
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Case report A 24-year-old healthy woman (para 1 + 1, A Rh +ve) had an uneventful pregnancy until 34 weeks gestation when breech presentation was noted. Attempted external cephalic version failed and an ultrasound scan was performed. This showed fetal ascites, scalp oedema and cardiomegaly. Four cardiac chambers were present, and the kidneys, bladder and spine were normal. Spontaneous labour at 36 weeks gestation proceeded to a normal vaginal delivery of a live female infant, Apgar score 8 at one minute. Her birth weight was 2800 g (50th centile) and head circumference 32.3 cm (10th centile). The only abnormal findings were an enlarged liver and spleen, each palpable 3cm below the costal margin. The baby remained well and the hepatosplenomegaly resolved by 7 days. calcification but an ultrasound scan showed no evidence of ventricular dilatation. The baby was treated with pyrimethamine (1 mg/kg/day as a single daily dose) and sulphonamide (100 mg/kg/day as two divided doses) for 21 days, with folinic acid (10 mg/day) supplementation and weekly full blood count estimation, as pyrimethamine is a folate antagonist. This was followed by spiramycin (100 mg/kg/day as a single daily dose) for 42 days. Four courses of pyrimethamine, sulphonamide and folinic acid for 21 days followed by spiramycin for 42 days will be given in the first year of life2. As there was evidence of active disease, prednisolone (1 mg/kg/day) was given until both the CSF protein had fallen and the chorioretinitis was healing. Regular ultrasound scans have shown no evidence of ventricular dilatation. The ocular lesions have healed leaving bilateral central scarring. At 21 weeks of age, the baby remained well with weight on the 10th centile and normal developmental progress.
Discussion
Hydrops fetalis is an unusual but recognized presentation of congenital toxoplasmosis. Sabin's classical trial of hydrocephalus, chorioretinitis and intracranial calcification was thought to be the usual outcome of congenital toxoplasmosis, and retrospective studies showed a high incidence of ocular sequelae and mental retardation. However, prospective studies from France2'3, measuring serial toxoplasmosis titres, demonstrated that of women who acquired toxoplasmosis during pregnancy at least 60% had unaffected babies, and that of those babies who were infected the majority had subclinical disease. Treatment of the mother who acquired infection during pregnancy with spiramycin reduced the overall frequency of fetal infection but not of overt disease3.
Prospective studies in the United Kingdom suggest that the incidence of overt and subclinical congenital toxoplasmosis is approximately 1 in 2000 live births"-5. All toxoplasmosis serology for England, Wales and Northern Ireland is performed at one of three Public Health Laboratories at Leeds, Swansea or Tooting, and it is therefore possible to ascertain the number of cases diagnosed. Prospective studies suggest an incidence of 80-160 cases of symptomatic congenital toxoplasmosis per year in England and Wales. However, only 34 cases of congenital toxoplasmosis were diagnosed in one 6-year period, implying considerable under-recognition'.
If infants who are symptomatic at birth are often undetected, then an even larger number of those with subclinical disease are also unrecognized. This is important, as a high proportion of infants with subclinical disease will later develop sequelae2'5'6.
In one series, of 47 patients with normal fimdi at birth, 31 later developed chorioretinitis2. Ventricular dilatation or chorioretinitis may develop at any time up to puberty, though it is suggested The Royal Society of Medicine that early treatment reduces the likelihood of these later complications. If the incidence is as high as suggested, there would therefore be an argument for screening pregnant women in the UK.
Treatment, therefore, is indicated not only for overt congenital toxoplasmosis but also for subclinical seropositive disease. Prednisolone is given if there is active disease as evidenced by high CSF protein or active chorioretinitis2. Steroids contribute to the healing of the uveitis as it is partly a secondary response to infection5.
The limited studies on the influence of treatment on the development of neurological sequelae suggest that it is beneficial. Wilson et al.6 report 22 children who presented with chorioretinitis but no neurological disease. Five of the 13 untreated children developed major neurological sequelae as compared with none of the 9 treated children. A small study7 of children with subclinical disease, comparing a treated group with an untreated group and controls, showed significantly reduced IQ and a nonsignificant reduction in gross and fine motor control in those untreated as compared with controls, while the treated group showed normal IQ and development. Thus it is generally felt that the various risks and consequences of subsequent neurological and ocular disease are so great as to make treatment justifiable2'3'6.
The present case illustrates the fact that congenital toxoplasmosis may present antenatally as hydrops fetalis. Where hydrops fetalis is diagnosed antenatally, congenital toxoplasmosis should be excluded by maternal serology. With the patient in the right lateral position, a spinal tap was performed without difficulty at the L3/4 level with a 26-gauge needle. There was free flow and easy aspiration of cerebrospinal fluid (CSF). Lignocaine 100 mg in 2 ml dextrose 7.5% with adrenaline 0.1 mg was administered and the patient turned supine within 30 seconds. Within five minutes the patient developed a unilateral block, on the right, with a sensory level at T6. There was no motor or sensory loss on the left side and the block remained unilateral despite tilting the left side down for ten minutes. With the patient in the left lateral position, a second spinal tap was performed without difficulty at the same level with a 26-gauge needle, directed so as to try to puncture the dura to the left of the midline. There was free flow and easy aspiration of CSF. Lignocaine 50 mg in 1 ml dextrose 7.5% with adrenaline 0.05 mg was administered. The patient was kept in the left lateral position for five minutes, during which time signs of a successful block on the left appeared; he was then turned supine.
The highest level of sensory block was T4 on the right and T6 on the left. Surgery was uneventful. The block regressed asymetrically, recovery being more rapid on the right than the left, with complete motor and sensory recovery within three hours.
As long ago as 1875, a posterior midline septum (septum posticum) in the subarachnoid space was described by Key and Retzius2. More recent work examining the posterior subarachnoid space in
